159 related articles for article (PubMed ID: 4016932)
1. Pupillary and vascular effects of calcium antagonists in migraine.
Fanciullacci M; Boccuni M; Pietrini U; Cangi F; Gatto G; Marabini S; Fusco BM
Cephalalgia; 1985 May; 5 Suppl 2():181-3. PubMed ID: 4016932
[TBL] [Abstract][Full Text] [Related]
2. Calcium channel antagonists and the treatment of migraine.
Greenberg DA
Clin Neuropharmacol; 1986; 9(4):311-28. PubMed ID: 2425960
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of calcium entry blockers in several models of immediate hypersensitivity.
Ritchie DM; Sierchio JN; Bishop CM; Hedli CC; Levinson SL; Capetola RJ
J Pharmacol Exp Ther; 1984 Jun; 229(3):690-5. PubMed ID: 6202868
[TBL] [Abstract][Full Text] [Related]
4. Augmentation by calcium channel antagonists of general anaesthetic potency in mice.
Dolin SJ; Little HJ
Br J Pharmacol; 1986 Aug; 88(4):909-14. PubMed ID: 2943355
[TBL] [Abstract][Full Text] [Related]
5. Nifedipine and flunarizine block amphetamine-induced behavioral stimulation in mice.
Grebb JA
Life Sci; 1986 Jun; 38(26):2375-81. PubMed ID: 3724362
[TBL] [Abstract][Full Text] [Related]
6. Calcium entry blockers and vascular smooth muscle heterogeneity.
Van Nueten JM; Vanhoutte PM
Fed Proc; 1981 Dec; 40(14):2862-5. PubMed ID: 7308496
[TBL] [Abstract][Full Text] [Related]
7. The effects of verapamil, prenylamine, flunarizine and cinnarizine on coronary artery occlusion-induced arrhythmias in anaesthetized rats.
Fagbemi O; Kane KA; McDonald FM; Parratt JR; Rothaul AL
Br J Pharmacol; 1984 Sep; 83(1):299-304. PubMed ID: 6487894
[TBL] [Abstract][Full Text] [Related]
8. Brainstem auditory evoked potentials in migraine patients in basal conditions and after chronic flunarizine treatment.
Bussone G; Sinatra MG; Boiardi A; La Mantia L; Frediani F; Cocchini F
Cephalalgia; 1985 May; 5 Suppl 2():177-80. PubMed ID: 4016931
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of flunarizine in the prophylaxis of migraine.
Centonze V; Tesauro P; Trizio T; Magrone D; Vino M; Macinagrossa G; Campanozzi F; Altomare E; Attolini E; Albano O
Cephalalgia; 1985 May; 5 Suppl 2():165-8. PubMed ID: 3893737
[No Abstract] [Full Text] [Related]
10. Atherosclerosis, calcium, and calcium antagonists.
Henry PD
Circulation; 1985 Sep; 72(3):456-9. PubMed ID: 3893790
[No Abstract] [Full Text] [Related]
11. Effects of calcium channel blockers on renal function in mice.
Honess DJ; Bleehen NM
Int J Radiat Oncol Biol Phys; 1992; 22(3):443-6. PubMed ID: 1735675
[TBL] [Abstract][Full Text] [Related]
12. In vitro effects of flunarizine on human lymphocytes.
Brohée D; Piro P; Kennes B; Nève P
Cytobios; 1986; 45(182-183):139-46. PubMed ID: 3731875
[TBL] [Abstract][Full Text] [Related]
13. Vascular reactivity and calcium-entry blockers.
Van Nueten JM; De Clerck F
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():575-83. PubMed ID: 6233852
[TBL] [Abstract][Full Text] [Related]
14. Polymorphonuclear leucocytes as a model of Ca++ and Mg++-dependent cellular activation. Effect of calcium entry blockers.
Di Perri T; Laghi Pasini F; Pasqui AL; Ceccatelli L; Orrico A; Capecchi PL
Int J Tissue React; 1985; 7(4):291-301. PubMed ID: 3934096
[TBL] [Abstract][Full Text] [Related]
15. Isolated rat cardiac myocytes as an experimental model to study calcium overload: the effect of calcium-entry blockers.
Donck LV; Pauwels PJ; Vandeplassche G; Borgers M
Life Sci; 1986 Mar; 38(9):765-72. PubMed ID: 3951332
[TBL] [Abstract][Full Text] [Related]
16. Non-vascular action of calcium blockers in migraine: pupillopharmacological study.
Fanciullacci M; Pietrini U; Nicolodi M; Sicuteri F
Funct Neurol; 1986; 1(4):533-7. PubMed ID: 3038706
[TBL] [Abstract][Full Text] [Related]
17. Ineffectiveness of organic calcium channel blockers in antagonizing long-term potentiation.
Taube JS; Schwartzkroin PA
Brain Res; 1986 Aug; 379(2):275-85. PubMed ID: 3017511
[TBL] [Abstract][Full Text] [Related]
18. The effects of flunarizine in experimental models related to the pathogenesis of migraine.
Wauquier A; Ashton D; Marrannes R
Cephalalgia; 1985 May; 5 Suppl 2():119-23. PubMed ID: 4016924
[TBL] [Abstract][Full Text] [Related]
19. Effects of calcium antagonists on serotonin and noradrenaline venoconstriction in humans.
Panconesi A; Franchi G; Anselmi B; Andreini R; Del Bianco PL
Clin Pharmacol Ther; 1988 Apr; 43(4):442-8. PubMed ID: 3356088
[TBL] [Abstract][Full Text] [Related]
20. Effects of calcium antagonists on mean circulatory filling pressure in the conscious rat.
Waite RP; Pang CC; Walker MJ
J Cardiovasc Pharmacol; 1988; 12(5):499-504. PubMed ID: 2468047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
